Niche clinical trials

Explore recruiting niche clinical trials.

Recruiting niche studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Niche trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Neoadjuvant immune checkpoint inhibition and novel IO combinations in early-stage colon cancer - the NICHE trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Repurposing Metformin as a Leukemia-preventive Drug in CCUS and LR-MDS

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, single-blind trial to evaluate the safety and efficacy of apraglutide in subjects with Grade II to IV (MAGIC) steroid refractory gastrointestinal (GI) acute graft versus host disease on best available therapy.

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. (STARS extend)

Spain, Denmark, Norway, Germany, France, Sweden +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Niche trials by city

Niche in Toronto Niche in Vancouver Niche in Montreal Niche in Calgary Niche in Edmonton Niche in Ottawa Niche in Winnipeg Niche in Quebec City Niche in Hamilton Niche in Kitchener Niche in London Niche in Halifax Niche in New York Niche in Los Angeles Niche in Chicago Niche in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease